Fig. 3From: A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health dataHazzard ratio time to discontinuation for patients undergoing methadone maintenance and buprenorphine/naloxone maintenance treatmentBack to article page